Holdings
Remedium Capital Partners, LLC
As of Sep 30, 2026, Remedium Capital Partners, LLC reported 4 positions worth US$213M. Largest: Spyre Therapeutics, Inc., Oruka Therapeutics, Inc. and Jade Biosciences, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Spyre Therapeutics, Inc. | 1.16M | US$103M | −304K | Sep 30, 2026 |
| Oruka Therapeutics, Inc. | 954K | US$79.5M | −612K | Sep 30, 2026 |
| Jade Biosciences, Inc. | 1.81M | US$25.4M | +230K | Sep 30, 2026 |
| Crescent Biopharma, Inc. | 361K | US$5.27M | no change | Sep 30, 2026 |